Mefloquine

FDA Approved: * December 29, 2003
Pharm Company: * BARR
Category: Malaria

Mefloquine, sold under the brand name Lariam among others, is a medication used to prevent or treat malaria.[3] When used for prevention it is typically started before potential exposure and continued for several weeks after potential exposure.[3] It can be used to treat mild or moderate malaria but is not recommended for severe malaria.[3] It is taken by mouth.[3] Common side effects include vomiting, diarrhea, headaches, sleep ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Mefloquine 54;111
Mefloquine Hydrochloride 250 mg Oral Tablet
NDC: 0054-0025
Labeler:
Roxane Laboratories, Inc.
Mefloquine b;171
Mefloquine Hydrochloride 250 mg Oral Tablet
NDC: 0555-0171
Labeler:
Barr Laboratories Inc.
Mefloquine b;171
Mefloquine Hydrochloride 250 mg Oral Tablet
NDC: 54569-6661
Labeler:
A-s Medication Solutions
Mefloquine b;171
Mefloquine Hydrochloride 250 mg Oral Tablet
NDC: 68071-4702
Labeler:
Nucare Pharmaceuticals, Inc.
Mefloquine b;171
Mefloquine Hydrochloride 250 mg Oral Tablet
NDC: 68788-6833
Labeler:
Preferred Pharmaceuticals Inc.
Mefloquine Hydrochloride 250 mg Oral Tablet
NDC: 0143-1282
Labeler:
West-ward Pharmaceutical Corp
Mefloquine Hydrochloride 250 mg Oral Tablet
NDC: 0781-5076
Labeler:
Sandoz Inc
Mefloquine Hydrochloride 250 mg Oral Tablet
NDC: 21695-449
Labeler:
Rebel Distributors Corp
Mefloquine Hydrochloride 250 mg Oral Tablet
NDC: 21695-561
Labeler:
Rebel Distributors Corp
Mefloquine Hydrochloride 250 mg Oral Tablet
NDC: 50090-2396
Labeler:
A-s Medication Solutions
More Results

Related Brands

Drugs with the same active ingredients